Department of Biostatistics and Epidemiology, Graduate School of Public Health, Medical Sciences Campus, University of Puerto Rico, San Juan, Puerto Rico.
Puerto Rico Central Cancer Registry, University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico.
J Low Genit Tract Dis. 2018 Jul;22(3):225-230. doi: 10.1097/LGT.0000000000000395.
The aim of the study was to estimate the magnitude of the association between HPV-related gynecological neoplasms and secondary anal cancer among women in Puerto Rico (PR).
We identified 9,489 women who had been diagnosed with a primary cervical, vaginal, or vulvar tumor during 1987-2013. To describe the trends of invasive cervical, vulvar, vaginal, and anal cancer, the age-adjusted incidence rates were estimated using the direct method (2000 US as Standard Population). Standardized incidence ratios (observed/expected) were computed using the indirect method; expected cases were calculated using 2 methods based on age-specific rates of anal cancer in PR. The ratio of standardized incidence ratios of anal cancer was estimated using the Poisson regression model to estimate the magnitude of the association between HPV-gynecologic neoplasms and secondary anal cancer.
A significant increase in the incidence trend for anal cancer was observed from 1987 to 2013 (annual percent change = 1.1, p < .05), whereas from 2004 to 2013, an increase was observed for cervical cancer incidence (annual percent change = 3.3, p < .05). The risk of secondary anal cancer among women with HPV-related gynecological cancers was approximately 3 times this risk among women with non-HPV-related gynecological cancers (relative risk = 3.27, 95% CI = 1.37 to 7.79).
Anal cancer is increasing among women in PR. Women with gynecological HPV-related tumors are at higher risk of secondary anal cancer as compared with women from the general population and with those with non-HPV-related gynecological cancers. Appropriate anal cancer screening guidelines for high-risk populations are needed, including women with HPV-related gynecological malignancies and potentially other cancer survivors.
本研究旨在估计波多黎各(PR)女性中 HPV 相关妇科肿瘤与继发性肛门癌之间的关联程度。
我们确定了 9489 名在 1987-2013 年间被诊断为原发性宫颈、阴道或外阴肿瘤的女性。为了描述浸润性宫颈癌、外阴癌、阴道癌和肛门癌的趋势,使用直接法(2000 年美国为标准人群)估计了年龄调整后的发病率。使用间接法计算标准化发病比(观察/预期);使用基于 PR 肛门癌年龄特异性发病率的 2 种方法计算预期病例。使用泊松回归模型估计肛门癌标准化发病比的比值,以估计 HPV-妇科肿瘤与继发性肛门癌之间的关联程度。
从 1987 年到 2013 年,观察到肛门癌的发病率呈显著上升趋势(年变化百分比 = 1.1,p <.05),而从 2004 年到 2013 年,宫颈癌的发病率呈上升趋势(年变化百分比 = 3.3,p <.05)。HPV 相关妇科癌症女性中继发性肛门癌的风险约为非 HPV 相关妇科癌症女性的 3 倍(相对风险 = 3.27,95%CI = 1.37 至 7.79)。
PR 女性的肛门癌发病率正在上升。与普通人群和非 HPV 相关妇科癌症的女性相比,患有妇科 HPV 相关肿瘤的女性发生继发性肛门癌的风险更高。需要为高危人群制定适当的肛门癌筛查指南,包括 HPV 相关妇科恶性肿瘤患者和可能的其他癌症幸存者。